Inato is improving access to clinical research by enabling community-based investigators to bring the right trials to their patients, regardless of who they are or where they live. To do this, our platform connects global pharmaceutical companies with a broader range of research sites, while ensuring reliable high performance through collaborative, evidence-based enrollment planning and ongoing support. By enabling community sites to select the right opportunities for them, we make trials more accessible, efficient and inclusive. For more information, visit inato.com

Helping Pharma and Biotechs in early stage Research, Analytics, Platform & Ecosystem Architecture and Cloud Solutions, to bring drugs faster to patients all around the world

Pangea is a growing team of exceptional sales, pre-sales and go-to-market resources. The team’s specific focus is to deliver high-end enterprise sales value to our clients of all sizes and demographics.Our team and board has extensive experience drawn from some of the world’s best technology companies and a long history of successfully growing businesses internationally. Our hiring approach is simple, we take on only full time employees who are at the peak of their growth potential.We provide the sales team your company needs with the speed and agility that today’s economy demands.

Veeva Systems is a leader in cloud-based solutions for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has over 200 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is headquartered in the San Francisco Bay Area, with offices in Philadelphia, Columbus, Toronto, Barcelona, Budapest, London, Paris, Beijing, Shanghai, Osaka, Tokyo, Sydney, and Singapore. For more information, visit www.eu.veeva.com

Thomson Reuters is the leading source of intelligent information for the world’s businesses and professionals, providing customers with competitive advantage. Intelligent information is a unique synthesis of human intelligence, industry expertise and innovative technology that provides decision-makers with the knowledge to act, enabling them to make better decisions faster. Through approximately 60,000 employees across more than 100 countries, we deliver this must-have insight to the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world’s most trusted news organization. Thomson Reuters shares are listed on the Toronto Stock Exchange and New York Stock Exchange (symbol: TRI) and our headquarters are located at 3 Times Square, New York, New York 10036.Our Intellectual Property & Science (IP&S) business provides comprehensive intellectual property (IP) and scientific information, decision support tools and services that enable governments, academia, publishers, corporations and law firms to discover, develop and deliver innovation.